ANKRD22 is a potential novel target for reversing the immunosuppressive effects of PMN-MDSCs in ovarian cancer

Huanhuan Chen(Jiangsu Province Hospital), Jianwei Zhou(Second Affiliated Hospital of Zhejiang University)
Journal for ImmunoTherapy of Cancer
February 1, 2023
Cited by 26


Related Papers